Study Overview
This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.
Description
Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial lung disease (ILD).
Official Title
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection (PHINDER)
Quick Facts
Study Start:2023-08-11
Study Completion:2025-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
| Inclusion Criteria | Exclusion Criteria |
|---|
| |
Contacts and Locations
Study Locations (Sites)
Pulmonary Associates
Phoenix, Arizona, 85032
United States
Hartford Hospital
Hartford, Connecticut, 06106
United States
Lakeland Regional Health
Lakeland, Florida, 33805
United States
NCH Healthcare System
Naples, Florida, 34102
United States
University of South Florida Health
Tampa, Florida, 33606
United States
Cleveland Clinic Florida
Weston, Florida, 33331
United States
Emory University Hospital
Atlanta, Georgia, 30322
United States
Piedmont Healthcare
Austell, Georgia, 30106
United States
Loyola University Chicago
Chicago, Illinois, 60153
United States
Northwestern University
Chicago, Illinois, 60611
United States
University of Kentucky Medical Center
Lexington, Kentucky, 40536
United States
LSU Health Sciences Center New Orleans
New Orleans, Louisiana, 70112
United States
University of Michigan Int Med Pulmonary and Critical Care
Ann Arbor, Michigan, 48109
United States
Mclaren Greater Lansing
Okemos, Michigan, 48864
United States
Blessing Health Hannibal
Hannibal, Missouri, 63401
United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03756
United States
Montefiore Medical Center
Bronx, New York, 10467
United States
NYU Langone Medical Center
New York, New York, 10016
United States
Duke University Medical Center
Durham, North Carolina, 27710
United States
Pulmonix, LLC
Greensboro, North Carolina, 27403
United States
East Carolina University
Greenville, North Carolina, 27834
United States
Legacy Health
Portland, Oregon, 97210
United States
St. Luke's University Health Network
Bethlehem, Pennsylvania, 18015
United States
AnMed Health Pulmonary and Sleep Medicine
Anderson, South Carolina, 29621
United States
Prisma Health
Columbia, South Carolina, 29203
United States
Premier Pulmonary Critical Care and Sleep Medicine
Denison, Texas, 75020
United States
Houston Methodist Hospital
Houston, Texas, 77030
United States
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229
United States
Intermountain Healthcare
Murray, Utah, 84107
United States
University of Utah Health
Salt Lake City, Utah, 84108
United States
The University of Vermont Medical Center
Burlington, Vermont, 05446
United States
Inova Fairfax Hospital
Falls Church, Virginia, 22042
United States
Sentara Cardiovascular Research Institute
Norfolk, Virginia, 23507
United States
Pulmonary Associates of Richmond
Richmond, Virginia, 23229
United States
Providence Medical Research Center
Spokane, Washington, 99204
United States
Marshall Health
Huntington, West Virginia, 25701
United States
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
United States
Collaborators and Investigators
Sponsor: United Therapeutics
Study Record Dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
Study Start Date2023-08-11
Study Completion Date2025-06
Study Record Updates
Study Start Date2023-08-11
Study Completion Date2025-06
Terms related to this study
Keywords Provided by Researchers
Additional Relevant MeSH Terms
- Interstitial Lung Disease
- Pulmonary Hypertension